Pharmaceuticals, Biotechnology and Life Sciences
– Pooled data from two pivotal Phase III open-label extension (OLE) studies show satralizumab was well-tolerated as a monotherapy or…
LONDON–(BUSINESS WIRE)–#GastrointestinalDiseasesTherapeuticsMarket–Technavio has been monitoring the gastrointestinal diseases therapeutics market and it is poised to grow by USD 22.82 billion…
LONDON–(BUSINESS WIRE)–#GastrointestinalDiseasesTherapeuticsMarket–Technavio has been monitoring the gastrointestinal diseases therapeutics market and it is poised to grow by USD 22.82 billion…
– First and only sublingual therapy approved for the on-demand treatment of Parkinson’s disease OFF episodes – – In a…
– First and only sublingual therapy approved for the on-demand treatment of Parkinson’s disease OFF episodes – – In a…
WILMINGTON, N.C.–(BUSINESS WIRE)–PPD, Inc. (Nasdaq:PPD) (the “Company”), a leading global contract research organization, today announced that Jaguar Holding Company II…
WILMINGTON, N.C.–(BUSINESS WIRE)–PPD, Inc. (Nasdaq:PPD) (the “Company”), a leading global contract research organization, today announced that Jaguar Holding Company II…
– Proven leader with extensive operational and commercial experience joins expanded Board CAMBRIDGE, Mass.–(BUSINESS WIRE)–Scholar Rock (NASDAQ:SRRK), a clinical-stage biopharmaceutical…
– Proven leader with extensive operational and commercial experience joins expanded Board CAMBRIDGE, Mass.–(BUSINESS WIRE)–Scholar Rock (NASDAQ:SRRK), a clinical-stage biopharmaceutical…
Chimeric antigen receptor (CAR)-NK cell therapy to treat the virus is one of more than two dozen COVID-19 research projects…